Content-type: text/html Suchergebnis - Abbildungen und Graphiken
Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Mobile Version
A-  |   A  |   A+
Werbung
 
Suchergebnis - Abbildungen und Graphiken
 
Alle Journale wurden nach Schlack W durchsucht Treffer 1 - 6 von 6

Medizinische Publikationen (1)  ::   Abbildungen und Graphiken  ::   Volltext (0)

Neue Suche:         Erweiterte Suche    Hilfe zur Suche

in allen Journalen nach  Bildtitel    Bildkeywords   Bildsummary   Autoren      Mindestens ein Wort  Alle Wörter   
1. Grunert S; Ebel D; Schlack W; Thämer V
Intracoronary and Intravenous Magnesium Does Not Reduce Myocardial Infarct Size in a Canine Model of Regional Ischaemia and Reperfusion
Magnesium - Infarktgröße
Journal of Clinical and Basic Cardiology 2002; 5 (1): 23-28
Infarct size as percentage of area at risk after intracoronary magnesium aspartate or placebo and intravenous magnesium potassium aspartate or placebo; values are single values and means +/- SD (filled symbols)

Keywords: Aspartateinfarct sizeInfarktgrößemagnesiummagnesiumMagnesiumaspartatmyocardial infarctionMyokardinfarkt
2. Grunert S; Ebel D; Schlack W; Thämer V
Intracoronary and Intravenous Magnesium Does Not Reduce Myocardial Infarct Size in a Canine Model of Regional Ischaemia and Reperfusion
Magnesium - Linksventrikulärer Druck
Journal of Clinical and Basic Cardiology 2002; 5 (1): 23-28
A: Left ventricular pressure (LVP) during intravenous infusion of magnesium potassium aspartate or placebo. B: Regional wall function in the anterior (ischaemic) and posterior (non-ischaemic) wall during intracoronary infusion of magnesium aspartate or vehicle (A-upper panel) and intravenous infusion of magnesium potassium aspartate or vehicle (B-lower panel). WThSYS = systolic wall thickening; Occl. = time period of left anterior descending coronary artery occlusion; Reperfusion = time period of left anterior descending artery reperfusion; Mg i.c. = time period when magnesium aspartate or vehicle was infused into the left anterior descending artery; Infusion i.v. = time period when magnesium potassium aspartate or vehicle was infused intravenously; values are means ± SD

Keywords: AspartateDiagrammDruckInfusionInfusionKaliumKaliumaspartatmagnesiummagnesiumMagnesiumaspartatpotassiumpressureventricleVentrikelwall functionWandbewegung
3. Grunert S; Ebel D; Schlack W; Thämer V
Intracoronary and Intravenous Magnesium Does Not Reduce Myocardial Infarct Size in a Canine Model of Regional Ischaemia and Reperfusion
Magnesium-Kalium-Aspartat - Herzfrequenz
Journal of Clinical and Basic Cardiology 2002; 5 (1): 23-28
Heart rate during administration of intravenous magnesium potassium aspartate in ischaemia-reperfusion. HR = heart rate; Occl. = time period of left anterior descending artery occlusion; Reperfusion = time period of reperfusion of the left anterior descending artery; Infusion i.v., time period when magnesium potassium aspartate or vehicle was infused intravenously; values are means +/- SD; Mg2+-K+ vs Control; P < 0.001

Keywords: AspartateDiagrammheart rateHerzfrequenzKaliumKaliumaspartatmagnesiummagnesiumMagnesiumaspartatpotassium
4. Grunert S; Ebel D; Schlack W; Thämer V
Intracoronary and Intravenous Magnesium Does Not Reduce Myocardial Infarct Size in a Canine Model of Regional Ischaemia and Reperfusion
Magnesium - Linksventrikulärer Druck
Journal of Clinical and Basic Cardiology 2002; 5 (1): 23-28
Left ventricular pressure (LVP) during intracoronary magnesium aspartate use (A-upper panel) and intravenous magnesium potassium aspartate use (B-lower panel). Occl. = time period of left anterior descending artery occlusion; Reperfusion = time period of left anterior descending artery reperfusion; Mg i.c. = time period when magnesium aspartate or vehicle was infused into the left anterior descending artery; Infusion i.v. = time period when magnesium potassium aspartate or vehicle was infused intravenously; values are means +/- SD

Keywords: AspartateDiagrammDruckInfusionInfusionmagnesiummagnesiumMagnesiumaspartatpressureventricleVentrikel
5. Grunert S; Ebel D; Schlack W; Thämer V
Intracoronary and Intravenous Magnesium Does Not Reduce Myocardial Infarct Size in a Canine Model of Regional Ischaemia and Reperfusion
Magnesium - Kalium - Serumkonzentration
Journal of Clinical and Basic Cardiology 2002; 5 (1): 23-28
Total serum concentration of magnesium and potassium during intravenous infusion of magnesium potassium aspartate or placebo. Occl. = time period of left anterior descending artery occlusion; Reperfusion = time period of reperfusion of the left anterior descending artery; Infusion i.v. = time period when magnesium potassium aspartate or placebo was infused intravenously; values are means +/- SD

Keywords: AspartateConcentrationDiagrammInfusionInfusionKaliumKaliumaspartatKonzentrationmagnesiummagnesiumMagnesiumaspartatpotassiumSerumSerum
6. Grunert S; Ebel D; Schlack W; Thämer V
Intracoronary and Intravenous Magnesium Does Not Reduce Myocardial Infarct Size in a Canine Model of Regional Ischaemia and Reperfusion
Magnesium - intrakoronar - intravenös
Journal of Clinical and Basic Cardiology 2002; 5 (1): 23-28
Experimental preparation and protocol of intracoronary magnesium (A) and intravenous magnesium (B) (time in min)

Keywords: Graphische DarstellungheartHerzmagnesiummagnesiummyocardiumMyokardprotocolProtokoll
 

 Seite 1 von 1 
 
copyright © 2000–2026 Krause & Pachernegg GmbH | Sitemap | Datenschutz | Impressum
 
Werbung